Cancer & Therapeutics


Cancer Therapeutics is to tackle the challenge of tumor heterogeneity, cancer evolution and resistance to drug treatments which include an ever-increasing array of tools at the disposal of clinicians in their treatment of this disease. It has endured a paradigm shift away from the traditional cytotoxic drugs towards the targeting of proteins intimately involved in driving the cancer phenotype. Cancer therapeutics has pursued the discovery and development of HSP90 inhibitors, as one way of preventing or overcoming drug resistance. All Anticancer agents act by depressing cell multiplication or normal functioning, DNA synthesis and by blocking or changing RNA and protein metabolite.



 


    Related Conference of Cancer & Therapeutics

    March 18-19, 2024

    5th Global Summit on Oncology and Hematology

    Zurich, Switzerland
    June 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Barcelona, Spain
    July 11-12, 2024

    24th World Congress on Cancer and Diagnostics

    Vancouver, Canada
    July 18-19, 2024

    14th World Congress on Breast Cancer

    Paris, France
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France

    Cancer & Therapeutics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in